Derek Cunningham
Optometrist · Austin, TXNPI 1265407084
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $582,247 of the $940,294 with a category attached, or 61.9%. 31 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 26.0% of the total. Among optometrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,483 payments — averaging $634.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$244K
- Bausch & Lomb Americas Inc.$239K
- Sight Sciences, Inc.$145K
- Shire North American Group Inc$56K
- Novartis$56K
- Alcon$49K
- plus $152K from 25 others
What the payments were for
- Consulting fees$244,00926%
- Speaking & faculty fees$582,24762%
- Travel & lodging$84,9079%
- Food & beverage$28,7573%
- Gifts$3730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 355 | $244,034 |
| Bausch & Lomb Americas Inc. | 414 | $238,545 |
| Sight Sciences, Inc. | 129 | $145,287 |
| Shire North American Group Inc | 90 | $56,230 |
| Novartis | 76 | $55,730 |
| Alcon | 107 | $48,558 |
| Kala Pharmaceuticals, Inc. | 67 | $42,994 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 56 | $35,917 |
| Eyevance Pharmaceuticals LLC | 50 | $27,847 |
| Johnson & Johnson Vision Care, Inc. | 2 | $15,030 |
| Oyster Point Pharma, Inc. | 35 | $9,628 |
| Harrow Eye, LLC | 16 | $7,371 |
| Alcon Research LLC | 1 | $2,700 |
| Johnson & Johnson Surgical Vision, Inc. | 9 | $2,048 |
| Bausch Health US, LLC | 1 | $2,000 |
| Vertical Pharmaceuticals, LLC | 1 | $1,750 |
| Beaver-visitec International, Inc. | 1 | $1,000 |
| Seagen Inc. | 1 | $990 |
| Tearlab Corp | 4 | $715 |
| Carl Zeiss Meditec, Inc. | 2 | $411 |
| Tarsus Pharmaceuticals, Inc. | 23 | $312 |
| AbbVie | 9 | $248 |
| Glaukos Corporation | 2 | $204 |
| ANI Pharmaceuticals, Inc. | 9 | $164 |
| Ocular Therapeutix, Inc. | 3 | $137 |
| Rxsight Inc | 5 | $120 |
| Dompe US, Inc. | 5 | $116 |
| Thea Pharma Inc. | 6 | $103 |
| Biotissue Holdings Inc. | 2 | $56 |
| Carl Zeiss Meditec USA, Inc. | 1 | $33 |
| Eyepoint US, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CEQUA$238,975
- XIIDRA$237,505
- MIEBO$181,028
- TearCare SmartLid$71,328
- TEARCARE(TM) (2.2) SYSTEM KIT$71,328
- VYZULTA$46,429
- TRYPTYR$45,909
- EYSUVIS$42,021
- TearCare$39,260
- TEARCARE SYSTEM$33,286
- LOTEMAX SM$26,184
- Acuvue$15,000
- Flarex$12,907
- TYRVAYA$8,910
- Tobradex ST$7,973
- BESIVANCE$7,401
- VEVYE$6,761
- Zerviate$6,708
- LOTEMAX$5,212
- ZYLET$4,669
How this compares
$940,294 in reported general payments places this provider in the 95th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 528 | $733,401 |
| RestasisCyclosporine | 84 | $106,159 |
| MieboPerfluorohexyloctane/Pf | 100 | $84,322 |
| CequaCyclosporine | 60 | $55,783 |
| Lotemax SmLoteprednol Etabonate | 137 | $34,382 |
| VevyeCyclosporine | 37 | $28,840 |
| VyzultaLatanoprostene Bunod | 36 | $15,564 |
| EysuvisLoteprednol Etabonate | 28 | $13,334 |
| ZyletTobramycin/Lotepred Etab | 33 | $11,513 |
| ProlensaBromfenac Sodium | 28 | $10,215 |
| TyrvayaVarenicline Tartrate | 13 | $9,047 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 22 | $5,629 |
| CombiganBrimonidine Tartrate/Timolol | 13 | $3,360 |
| Brimonidine Tartrate | 15 | $2,861 |
| Alphagan PBrimonidine Tartrate | 13 | $2,708 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra, Miebo, Vyzulta | $238,545 | $833,287664 claims |
| AbbVieRestasis, Combigan, Alphagan P | $248 | $112,227110 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLotemax Sm, Zylet, Prolensa | $35,917 | $56,110198 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $244,034 | $55,78360 claims |
| Harrow Eye, LLCVevye | $7,371 | $28,84037 claims |
| Kala Pharmaceuticals, Inc.Eysuvis | $42,994 | $13,33428 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $9,628 | $9,04713 claims |
| AlconSimbrinza | $48,558 | $5,62922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,315 optometrist providers in Texas.
Other optometrist in Austin
- Emile FadelAustin$225K
- Drew ProvostAustin$37K
- Marisol GomezAustin$30K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$547K
- Luis RojasMcKinney$309K
- Bridgitte LeeHouston$222K
- Phillip BrunsonHouston$214K
- Jill AutryBellaire$171K
- Stacie VirdenWaco$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.